Application | Comment | Organism |
---|---|---|
medicine | design of inhibitors with enhanced potency against proteolytic enzymes has many applications for treatment of human diseases | Penicillium janthinellum |
Crystallization (Comment) | Organism |
---|---|
crystal structure in complex with inhibitor PPi3, monoclinic space group C2, a : 96.24 A, b : 46.47 A, c : 65.38 A, crystal structure in complex with inhibitor PPi4, monoclinic space group C2, a : 96.98 A, b : 46.65 A, c : 65.71 A | Penicillium janthinellum |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
methyl cyclo[(2S)-2-[[(1R)-1-(N-(l-N-(3-methylbutanoyl)valyl-L-aspartyl)amino)-3-methylbutyl]hydroxyphosphinyloxy]-3-(3-aminomethyl)] phenylpropanoate | phosphonate-based macrocycle PPi4, macrocyclic pentapeptide inhibitor | Penicillium janthinellum | |
methyl cyclo[(2S)-2-[[(1R)-1-(N-(l-N-(3-methylbutanoyl)valyl-L-aspartyl)amino)-3-methylbutyl]ydroxyphosphinyloxy]-3-(3-aminomethyl)] phenylpropanoate | - |
Penicillium janthinellum |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Penicillium janthinellum | P00798 | - |
- |
Synonyms | Comment | Organism |
---|---|---|
Penicillium janthinellum aspartic proteinase | - |
Penicillium janthinellum |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0000001 | - |
methyl cyclo[(2S)-2-[[(1R)-1-(N-(l-N-(3-methylbutanoyl)valyl-L-aspartyl)amino)-3-methylbutyl]ydroxyphosphinyloxy]-3-(3-aminomethyl)] phenylpropanoate | pH 4.6, macrocyclic pentapeptide inhibitor | Penicillium janthinellum |